MedPath

BYETTA

BYETTA

Discontinued
DIN Number

02361817

Drug Class

Human

Market Date

May 31, 2011

Company
HC

astrazeneca canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02361817
AIG Number0152872004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BJ01 EXENATIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification

ACTIVE INGREDIENTS (1)

EXENATIDEActive
Strength: 10 MCG / ACT
Monograph: EXENATIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.